FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL)



Pettitt, AR, Polydoros, F, Dodd, J, Oates, M, Lin, K, Kalakonda, N, McCarthy, H, Bloor, A, Schuh, A, Duncombe, A
et al (show 6 more authors) (2016) FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL). .

[img] Text
CLL210 EHA 2016 Final Version.docx - Submitted Version

Download (26kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 11 Apr 2017 10:39
Last Modified: 09 Jan 2021 09:10
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3006822